Vaccine exposure to temperatures below recommended ranges in the cold chain may decrease vaccine potency of freeze-sensitive vaccines leading to a loss of vaccine investments and potentially places children at risk of contracting vaccine preventable illnesses.
Introduction
Immunizations are hailed as one of the most important public health interventions known saving millions of lives every year. Vaccines are responsible for the eradication of smallpox and the global community is currently working towards the eradication of polio. To reach current disease elimination and eradication targets, high immunization coverage rates are required. A wellfunctioning cold chain is at the center of ensuring potent vaccines reach their intended population in an equitable and timely manner [2, 3] .
Vaccines are biological products that slowly become inactive over time and must be kept within narrow temperature ranges from manufacturers to those receiving them [3] . When exposed to temperatures outside of this narrow range, the loss of potency may be accelerated [4] . Before 2007, attention had been focused on examining the effects of vaccine exposure to heat. However, exposure to freezing temperatures are equally damaging to the quality of many vaccines as the process renders them inactive [4] . When exposed to freezing temperatures, the adjuvants contained in some vaccines clump together adversely affecting the immunological properties of these vaccines [4] . Thus, the World Health Organization (WHO) recommends the following vaccines be stored and transported at 0-10°C: Diptheria-tetanus containing vaccines, tetanus toxoid (TT), hepatitis A and B, human papillomavirus (HPV), meningitis C, pneumococcal (PCV), cholera, influenza, haemophilus influenza b (Hib), typhoid and inactivated poliovirus (IPV) [4] . In 2015, approximately 59% of vaccines procured from the United Nations Children's Fund (UNICEF) Supply Division's (SD) catalogue are freeze-sensitive [5] . Furthermore, the number of freeze-sensitive vaccines recommended by the WHO has increased by 50% over the last ten years [4, 6] .
In 2007, a review of studies examining temperatures in the vaccine cold chain from 1985 to 2006 reported that in all segments of distribution, vaccines in 75-100% of monitored vaccine shipments had been exposed to freezing temperatures [1] . This 2007 review seems to have raised awareness about the risks of vaccine exposure to freezing temperatures in both developed and developing countries of varying climates.
The objective of this updated review is to examine the results of more recent monitoring studies regarding freezing temperatures within the immunization supply chain.
Methods

Identification of temperature monitoring studies
For this review, seven search terms were used alone and in combination to search gray and peer reviewed literature in PubMed, Popline, Embase, Biosis, and Google Scholar. In addition, the WHO and TechNet21 websites were searched for gray literature. The search terms were (i) vaccine, (ii) temperature, (iii) thermostability, (iv) storage, (v) transport, (vi) freeze, and/or (vii) cold chain. All searches were limited to studies published between July 2006 to August 2015, and did not include studies from Matthias et al. [1] . In addition, unpublished studies that evaluated the temperature of the storage of vaccines either in facilities, during transportation or at outreach sessions in any country were included in this review.
Data extraction
The following information was extracted from each of the studies that met the inclusion criteria:
1. Year the study was published. 2. Year the study was conducted. 3. The country in which the study was conducted. 4. Type of temperature measuring equipment used. 5. Freeze threshold temperature or the temperature that was considered ''too cold". 6. Duration vaccines were at or below the freeze threshold (the time threshold after which was considered as ''too cold"). 7. The duration of temperature monitoring. 8. The frequency of temperature monitoring. 9. Unit of analysis (refrigerators, transport in vaccine carriers, transport in refrigerated trucks, etc.). 10. Study sample size (number of refrigerators or shipments). 11. Number of samples that registered freezing temperatures. 12. Percentage of samples that registered freezing temperatures or temperatures out of the recommended range of 2-8°C. 13. Minimum temperatures observed.
Analysis
Data were analyzed from studies that reported temperature monitoring results. Different segments of the cold chain were analyzed separately to account for differences in endpoints across studies. Analysis of data from published studies includes means and standard deviations (SD) of study sample sizes and years of studies as well as the weighted means and SDs of the percent of samples found below recommended temperatures. Some studies provide temperature data for more than one administrative level and for more than one cold chain segment; therefore, an individual study may have multiple data points. In addition, each country was categorized by region and World Bank income status [7] . Wealthier countries are defined as those with upper-middle to high income status and lower income countries are defined as those in low to lower-middle income status.
Rigorous monitoring was defined as studies in which both the frequency and duration of exposure to temperatures below recommended temperatures were reported. For duration of monitoring, anything more than 1 week was assigned a 1 and less was assigned a 0. For frequency of monitoring, any study with continuous monitoring was given a 1, while spot checks or one time point only measurements were given a 0. Rigor was calculated by then multiplying the two to determine a single indication (0 or 1). Rigorous studies were identified by a 1.
Data was entered, stored and tabulated in Excel TM (Microsoft, Redmond, WA).
Results
The literature and web search was completed on March 21, 2016 and yielded 1070 articles. Screening of these articles led to the removal of 889 citations based on relevance of abstracts and titles. The remaining 181 full text citations were screened according to the study inclusion criteria. The secondary and final screen yielded 45 articles for final inclusion in the review (Tables 1 and 2) .
Of the 45 articles, 33 are from peer-reviewed journals and 12 are from gray or unpublished literature. Thirteen articles describe temperature monitoring data from the African region, 12 from the Western Pacific region, nine from the South East Asian region, three from the Americas, four from the Eastern Mediterranean and four from Europe.
Studies from all income levels are represented. Seven studies are from high-income countries (HIC), 13 are from upper-middle income countries (UMIC), 15 are from lower-middle income countries (LMIC) and eight are from low-income countries (LIC). Two Table 1 Vaccine cold chain studies reporting storage, transport, or immunization session temperatures below the recommended range included in both the literature review and the analysis.
No. Article
Peer articles describe data from more than one country and these countries represent various income levels. Studies defined the threshold for low, cold or freezing temperatures at or below 2°C in 37 studies; however, three studies defined the threshold at or below 0°C and five studies did not specifically mention a low threshold. The lowest temperature reported was À21.3°C and the highest reported was 31.7°C. Complete temperature ranges were not available in 31 studies. Eighteen studies evaluated storage units or shipments that fell out of the recommended range of 2-8°C, however, they did not specify exact temperatures or whether freezing occurred.
Assessment of the cold chain at a national level was performed in seven studies, the provincial or regional level in 20 studies and the district level in 35 studies. One study did not specify an administrative level.
All cold chain segments were represented in the final 45 articles. The storage segments alone were evaluated in 29 articles and four articles only examined the transport segment. Eight articles studied storage and transport segments; three studies examined storage, transport and outreach sessions and one article studied storage and outreach sessions.
The sample size of the studies varied, ranging from one to 103 shipments or from three to 440 storage units. Storage units were described as walk-in-coolers, domestic refrigerators, ice-lined refrigerators, kerosene electric refrigerators, purpose built refrigerators, bar-type refrigerators, cold boxes, vaccine carriers and study boxes. The transport segments and outreach sessions utilized vaccine carriers or cold boxes.
Further analysis concentrating on data from studies that assessed vaccine exposure to temperatures below recommended ranges included 21 articles (Table 1) . Twenty-four studies were excluded based on a lack of information. This analysis found that the percent of shipments found below recommended temperatures in wealthier countries was 38% and 19.3% in lower income countries. The percent of storage units where vaccines were exposed to temperatures below recommended ranges were 33.3% in wealthier countries and 37.1% in lower income countries. Three temperature monitoring studies during outreach sessions were found in lower income countries and none were found from wealthier countries. The percent of vaccine exposure to tempera-tures below recommended ranges during outreach sessions was 18% ( Table 3) .
Recommendations were included in all studies and the most commonly cited recommendation for countries are to conduct training sessions (19 articles), to improve supervision (10 articles) and the need for policies and guidelines (5 articles).
Discussion
Matthias et al. [1] identified 35 articles published between 1985 and June 2006 that assessed vaccine exposure to 'too cold' temperatures, which equates to an average of 1.7 articles per year. This update identified 21 articles in the last 10 years with data assessing vaccine exposure to temperatures below the recommended range in vaccine cold chains, which is a rate of 2.1 articles on average per year. This may indicate a slight increase in awareness of vaccine exposure to freezing temperatures. Over the last ten years, improvements in cold chain monitoring have been reported due to newer cold chain technology and more studies are implementing rigorous temperature monitoring techniques, as defined in this article, than were reported in 2007 [1] . In Vietnam, continuous temperature monitoring systems showed that vaccines in vaccine carriers monitored during the study were not exposed to temperatures below 0°C and enabled the country to identify temperature excursions during storage and outreach sessions [8] . Similarly, exposure to temperatures below recommended ranges during transport decreased by 12.1 percentage points and freeze alarms were reduced by 40% in Tunisia due to the use of continuous temperature monitoring and Phase Change Material (PCM) transport packs [9] . India reported significant improvements in the maintenance of cold chain temperatures after reorganizing the cold chain and training health workers [10] .
The same analysis completed by Matthias et al. [1] (Table 3 ) was also completed in this updated review. Since 2007, a greater number of articles from low to lower-middle income countries have completed studies examining the transport and outreach segments of the cold chain.
The occurrence of temperatures below the 'too cold' threshold in studies that monitored temperatures during transport showed that shipments in lower income countries was 35.3% in the set of [1] . Shipments exposed to 'too cold' temperatures in wealthier countries were 16.7% in the 2007 paper (38% here). However, the percent of rigorous studies, as defined here, conducted during transport was 50% for wealthier countries in 2007 (50% here) and 78% for lower income countries (50% here Table 3 ).
In studies that monitored temperatures during vaccine storage, the occurrence of exposure to temperatures considered 'too cold' in wealthier countries was 29% in 2007 (33.3% here), and 21.9% in lower income countries in 2007 (37.1% here). The percentage of storage monitoring studies with rigorous methods, in lower income countries was 50% in 2007 (50% here). For wealthier countries, rigorous methods were found in 29% of storage monitoring studies in 2007 (70% here Table 3 ).
A possible reason for the differences in findings between the two papers is the percentage of studies with rigorous methods. This is important since Matthias et al. found that rigorous studies were a significant predictor of exposure to temperatures below recommended ranges. Since rigor, as defined here, takes into account continuous monitoring and the duration of monitoring, the longer the duration, the more likely a 'too cold' event is to be discovered. Thus, for instance, the decrease in shipments in lower income countries observed with 'too cold' events between the two studies may, in part, be due to the inclusion of studies with less continuous monitoring in this study as compared to the 2007 article. These factors should be considered in the study design of future temperature monitoring studies.
Recommendations ranged from technical guidance of vaccine placement in storage units and cold chain product preferences to the development of local and national guidelines. The majority of studies recognized the importance of engaging all segments of cold chain staff by providing ongoing educational sessions and training sessions aimed at new staff members [11] [12] [13] [14] . Supervision was another area of concern. Some articles mentioned the designation of one or two persons to supervise cold chain temperatures as a way to improve supervision and accountability [15, 16] . Finally, some articles reported a need for the development of local or national guidelines [17, 18] to have clear back up plans to reduce vaccine loss in the event of electrical failure and a need for making current guidelines readily available to staff [19, 20] .
Of utmost importance is the link between vaccine exposure to temperatures below recommendations and disease outbreaks. In a 20-year period, Micronesia did not have a single reported case of measles. However, in 2014 a relatively large measles outbreak occurred where more than half of all cases were vaccinated adults [21] . Micronesia's cold chain had a history of cold chain breaches, including freezing temperatures during transport, which point to possible causes of vaccine failure [21] . Ambient freezing temperatures during winter in Mongolia can be as low as À15°C. Though the temperatures of vaccine storage units were not evaluated, children vaccinated during winter months were over two times more likely to become diagnosed with Hepatitis B implying the inactivation of Hepatitis B vaccine due to exposure to freezing temperatures [22] . Finally, a study in the United States noted that health regions with higher percentages of refrigerators with frozen temperatures also had higher rates of pertussis [23] .
Although this study presents current information on vaccine temperature monitoring and vaccine exposure to temperatures considered 'too cold', there are several limitations. Altogether, these studies represent a very small number of worldwide shipments, storage units and outreach sessions. Also, the number of studies from upper-middle to high-income countries is similar to those from low to -lower-middle income countries; however, more studies are from the African (12) and West Pacific (12) regions. Thus, while these study findings may be indicative, it is difficult to characterize them as representative of the global reality.
Studies were subject to a variety of biases. Selection bias may have occurred in the selection of study sites or shipment routes. It is difficult to discern if, in some studies, sites or routes were chosen due to past good performance, new equipment or ease of accessibility.
Conclusion
This updated review highlights continuing issues of vaccine exposure to 'too cold' temperatures during various segments of the cold chain. The number of rigorous studies available from countries has increased and plays an important role in the detection of 'too cold' temperatures. Since 2007, the number of freeze-sensitive vaccines procured by UNICEF Supply Division (SD) for countries immunization programs increased by 50%. In 2015, freeze-sensitive vaccines procured through UNICEF SD totaled a value of $1.2 billion USD [24] , highlighting the importance of monitoring vaccine exposure to 'too cold' temperatures. More rigorous monitoring studies are needed as well as more research to better understand instances of vaccine exposure to 'too cold' temperatures and the link to disease outbreaks. As freezing remains a problem, the new categories of prequalification status for user independent freeze-free cold chain equipment will be necessary. In addition, the emergence of actual technologies on the market that meet freeze safety standards and uptake of these technologies by consumers will be essential. Finally, until thermostable vaccines and freeze-free technologies become available in every country, countries can improve vaccine exposure to freezing by implementing continuous temperature monitoring, improving health worker training, accountability, supervision and the access and development of national and local guidelines regarding vaccine storage and freezing vaccines.
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